Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2025-12-24 @ 7:46 PM
NCT ID:
NCT02411903
Eligibility Criteria:
Inclusion Criteria:
* The patient must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
* Age \<85 years and \>45 years ,Male or female.
* The patient have been Cerebral infarction for one month.
* national institutes of health stroke scale（NIHSS）score ≤23 points.
* Blood Platelet count greater than 150×10\^9／L,and Less than 500×10\^9／L.
* The patient never do not taking aspirin 、dipyridamole、clopidogrel,or the patient had been taken these anti-platelet drugs but has been discontinued for two weeks at least.
* The patient never do not taking Statins or the patient have been stop taking statins 2 weeks for two weeks.
Exclusion Criteria:
* Allergic constitution , or allergic to the composition of the drugs in this study.
* national institutes of health stroke scale（NIHSS） score \>23 points.
* Atrial fibrillation and other cardiogenic cerebral embolism.
* Patients who were undergone surgery and trauma (including fractures) within the past three month.
* Patients with known dysfunction of vital organs or suffered from Serious cardiovascular disease ，or coagulation disorders.
* The patient took Proton pump inhibitors recently.
* The history of data collection and the follow-up process can not be saved.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
85 Years
Study:
NCT02411903
Study Brief:
Protocol Section:
NCT02411903